Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
In developed countries gastrointestinal symptoms are a common reason for attendance to primary care clinics and to hospital outpatients
Hsieh MJ, Lee CH, Chueh HY, Chang GJ, Huang HY, Lin Y, et al
rapid degradation limits systemic exposure
The CREDENCE clinical trial evaluated the effects of canagliflozin 100 mg daily versus placebo in 4401 patients with T2DM and chronic kidney disease (CKD)
Suspected adverse reactions should be reported via the MHRA Yellow Card Scheme
US$ 24.36
US$ 24.20
:max_bytes(150000):strip_icc()/Health-GettyImages-1675158771-70640c9fdf1b41078975cfc3fd538a6b.jpg)
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 26.87
